About Immago Biosystems
Immago Biosystems is a Healthcare company based in Cheltenham (United Kingdom) founded in 2013 by Kavitha Baruah, Chris Scanlan, and Max Crispin, and was acquired by Hansa Biopharma in July 2016. The company has 6 employees. The company was acqui-hired. Its focus areas include Life Sciences, Oncology, Drugs and Diversified. Its legal entity is HANSA BIOPHARMA LIMITED.
Company details
Developer of immunotherapeutics for cancer treatment. It offers therapeutic antibodies based on glycobiology by using antibody-modulating enzymes for antibody-based cancer treatments.
- Headquarters Cheltenham, United Kingdom
- Employees 6
- Founders Kavitha Baruah, Chris Scanlan, Max Crispin
- Stage Acquired
- SectorsHealthcare
- Website immago.co.uk
- Acquired by Hansa Biopharma (Jul 2016)
- Legal Name Hansa Biopharma Limited
- Date of Incorporation 15 Jan, 2013
- Jurisdiction GODALMING, SURREY, UNITED KINGDOM
- Investors
- Employee Count6
- Acquired byHansa Biopharma
(Jul 2016)
Investors in Immago Biosystems
Immago Biosystems has secured backing from 1 investor. Prominent investors backing the company include Hansa Biopharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Therapeutics for rare immunological diseases are developed and commercialized. | 2007 | hansabiopharma.com | Lund, Sweden |
Investor details for Immago Biosystems
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Immago Biosystems
3 people are tracked at Immago Biosystems (3 in leadership); the tracked headcount is 6.
| Name | Role | Group |
|---|---|---|
Kavitha Baruah | Co-Founder | Leadership |
Chris Scanlan | Co-Founder | Leadership |
Max Crispin | Co-Founder | Leadership |
Complete people profiles for Immago Biosystems
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Immago Biosystems
2 dated milestones of Immago Biosystems across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Immago Biosystems is founded.
- Exit Acquired by Hansa Biopharma.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Immago Biosystems
Immago Biosystems was founded in 2013.
Immago Biosystems is headquartered in Cheltenham, United Kingdom. It is registered at Cheltenham, Gloucestershire, United Kingdom.
Immago Biosystems has 6 employees.
Developer of immunotherapeutics for cancer treatment. It offers therapeutic antibodies based on glycobiology by using antibody-modulating enzymes for antibody-based cancer treatments.
Immago Biosystems has 1 investor. Key investors include Hansa Biopharma.
Immago Biosystems operates through Hansa Biopharma Limited.
Yes. Immago Biosystems was acquired by Hansa Biopharma in July 2016.